Hans Schambye

Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis

Nikhil Hirani, Alison C. MacKinnon, Lisa Nicol et al. · European Respiratory Journal · 2020 · 219 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Galectin‐3‐Binding Glycomimetics that Strongly Reduce Bleomycin‐Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition

Tamara Delaine, P.M. Collins, Alison C. MacKinnon et al. · ChemBioChem · 2016 · 198 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Identification of peptide binding residues in the extracellular domains of the AT1 receptor.

Siv A. Hjorth, Hans Schambye, William J. Greenlee et al. · Journal of Biological Chemistry · 1994 · 170 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade

Lynda Vuong, Eleni Kouverianou, Claire Rooney et al. · Cancer Research · 2019 · 141 citations · Full text

Medicine, Immunology, Oncology +16

Glycosylation of an N-Terminal Extension Prolongs the Half-Life and Increases the in Vivo Activity of Follicle Stimulating Hormone

Signe Perlman, Bart van den Hazel, Jesper Riis Christiansen et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 132 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16